Seek Returns logo

ASND vs. THC: A Head-to-Head Stock Comparison

Updated

Here’s a clear look at ASND and THC, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.

Company Overview

THC stands out with 15.12 billion USD in market value—about 1.58× ASND’s market cap of 9.55 billion USD.

THC carries a higher beta at 1.63, indicating it’s more sensitive to market moves, while ASND remains steadier at 0.40.

ASND trades as an ADR, giving U.S. investors a simple on-ramp to its foreign shares, while THC remains a standard domestic listing.

SymbolASNDTHC
Company NameAscendis Pharma A/STenet Healthcare Corporation
CountryDKUS
SectorHealthcareHealthcare
IndustryBiotechnologyMedical - Care Facilities
CEOMr. Jan Moller MikkelsenDr. Saumya Sutaria M.D.
Price158.1 USD162.83 USD
Market Cap9.55 billion USD15.12 billion USD
Beta0.401.63
ExchangeNASDAQNYSE
IPO DateJanuary 28, 2015March 17, 1980
ADRYesNo

Performance Comparison

This chart compares the performance of ASND and THC over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).

Hover over the lines to see the investment’s value and total return (%) at specific dates.

Data is adjusted for dividends and splits.

Valuation Metrics Comparison

The section examines key financial ratios to assess the valuation of ASND and THC based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.

  • ASND posts a negative P/E of -24.55, reflecting last year’s net loss, while THC at 10.55 signals healthy earnings.
  • ASND posts a negative forward PEG of -2.23, hinting at anticipated earnings decline, whereas THC at 0.48 has projections for stable or growing earnings.
  • ASND has a negative P/B ratio of -44.20, indicating its liabilities exceed assets (negative equity). THC, with a P/B of 3.67, maintains positive shareholder equity.
  • ASND has a negative Price-to-Free Cash Flow ratio of -27.43, signaling it consumed more cash than it produced over the last year—an important liquidity warning. In contrast, THC (P/FCF 10.64) indicates positive free cash flow generation.
SymbolASNDTHC
Price-to-Earnings Ratio (P/E, TTM)-24.5510.55
Forward PEG Ratio (TTM)-2.230.48
Price-to-Sales Ratio (P/S, TTM)22.890.74
Price-to-Book Ratio (P/B, TTM)-44.203.67
Price-to-Free Cash Flow Ratio (P/FCF, TTM)-27.4310.64
EV-to-EBITDA (TTM)-35.745.70
EV-to-Sales (TTM)23.781.23
EV-to-Free Cash Flow (TTM)-28.5017.79

Dividend Comparison

Neither ASND nor THC currently pays a dividend yield; this often indicates they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.

SymbolASNDTHC
Dividend Yield (TTM)0.00%0.00%

Financial Strength Metrics Comparison

This section dives into the financial resilience of ASND and THC, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.

  • ASND’s quick ratio of 0.71 suggests it may struggle to cover immediate liabilities without selling inventory or raising cash, whereas THC at 1.70 maintains a comfortable buffer of liquid assets.
  • ASND shows negative equity (debt-to-equity ratio -4.46), while THC is heavily leveraged (3.15), illustrating two different balance-sheet risks.
  • With negative EBIT (-3.72), ASND cannot cover its interest payments. THC, with an interest coverage of 5.80, meets its interest obligations.
SymbolASNDTHC
Current Ratio (TTM)1.041.78
Quick Ratio (TTM)0.711.70
Debt-to-Equity Ratio (TTM)-4.463.15
Debt-to-Assets Ratio (TTM)0.800.45
Interest Coverage Ratio (TTM)-3.725.80